JV 001
Alternative Names: JV-001Latest Information Update: 26 Dec 2023
At a glance
- Originator Shanghai Juvensis Therapeutics Biotechnology
- Class Gene therapies; Heart failure therapies; Recombinant proteins
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase 0 Heart failure